StockWatch
·

IFGL Refractories Ltd

BSE: 540774

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
325.33
+8.9%+12.8%
Expenditure
300.85
+8.3%+12.1%
Net Profit
18.32
+16.1%+23.3%
OPM %
10.21%
+0.36pp-2.27pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
-43.0358.93160.88262.84364.80Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q1 FY27Q2 FY27
Price Chart
Reports

IFGL Refractories: consol PAT doubles YoY to ₹25.7 Cr, adjusted ~33%, margins expand

refractories · margin expansion · overseas turnaround

ResultsQ2 FY2713 Nov 20263 minIndustrials & Infra

International Strength Masks Domestic Slowdown; Margins Stay Pinched

refractories · margin compression · international turnaround

Result verdictFollow-upQ1 FY2717 Aug 20266 minIndustrials & Infra

Margin pinch amid solid international; domestic slipping

margin compression · cost inflation · US growth

TranscriptDeep diveQ1 FY2717 Aug 20266 minIndustrials & Infra
Latest
Board Meeting13 Nov, 3:37 pm

IFGL Refractories: consol PAT doubles YoY to ₹25.7 Cr, adjusted ~33%, margins expand

IFGL Refractories' consolidated PAT came in at ₹25.7 Cr for Q2 FY27, up ~103% YoY (₹12.7 Cr) and up ~51% QoQ, on consolidated revenue of ₹553.1 Cr (+13.2% YoY, +8.0% QoQ). But the YoY jump flatters the underlying trend: roughly ₹6.7 Cr of the gain comes from goodwill amortisation (from the 2016 IFGL–Monocon merger) running off to nil after March 2026 — a charge the year-ago quarter still carried — and a further chunk from the European subsidiary flipping from a ₹7.36 Cr segment loss a year ago to a ₹0.89 Cr profit this quarter. Stripping these largely non-recurring/structural items out, underlying YoY PAT growth is closer to ~33%, which is the number that should anchor any read of this result — still a genuinely good quarter, not the headline-doubling it first appears. Margins did expand on an operating basis: consolidated OPM (EBITDA/revenue) rose to 8.83% from 7.77% a year ago and 7.22% last quarter, with NPM up to 4.63% from 2.59% YoY. The expansion sits mainly on raw-material and other-expense lines growing slower than revenue, consistent with better overseas mix (America segment result nearly doubled YoY to ₹10.6 Cr from ₹5.6 Cr) layering on top of the amortisation tailwind. Management's own standing guidance — a double-digit consolidated EBITDA margin and double-digit domestic growth by FY27-end — is on track but not yet fully met: domestic (India) revenue grew 12.2% YoY this quarter to ₹319.7 Cr, clearing the double-digit bar, while H1 domestic growth (9.86%) still trails it; margin at 8.83% is improving but short of the double-digit target. No management press release was available to cross-check tone beyond the filing itself, and no verified street/consensus estimate for this print turned up in search, so vs-street is unknown rather than assumed. The standalone (India-only) entity tells a steadier story — PAT up 23.3% YoY to ₹18.3 Cr on revenue up 12.7% to ₹323.3 Cr — underscoring that most of the consolidated beat is an overseas/accounting story, not a domestic acceleration; readers comparing the two sets of numbers should not read the gap as an error. Subsequent to the quarter, the company terminated its JV agreement with Marvels International Group (Seychelles) and Marvel Refractories (Anshan) of China effective October 14, 2026, and charged off ₹1.5–1.7 Cr against the related IFGL-Marvels Refractories investment/capex on prudence grounds pending a valuation change — a modest, flagged item that doesn't affect this quarter's core P&L materially.

13 Nov 2026, 03:37 pm

Corporate Events

Board MeetingIFGLEXPOR
2026
13Nov

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗
Board MeetingIFGLEXPOR
2026
5Aug

Board Meeting

The 19th Annual General Meeting (AGM) of the Members of IFGL…

BSE Filing ↗
DividendIFGLEXPOR
2026
29Jul

₹2.15 / share

BSE Filing ↗
Board MeetingIFGLEXPOR
2026
30May

Board Meeting

The board meeting is scheduled to consider and approve audit…

BSE Filing ↗
DividendIFGLEXPOR
2025
6Jun

₹6 / share

BSE Filing ↗
Board MeetingIFGLEXPOR
2025
8Feb

Board Meeting

consider and approve unaudited financial results, both on st…

BSE Filing ↗
Board MeetingIFGLEXPOR
2024
9Nov

Board Meeting

Considering and approving unaudited financial results, both …

BSE Filing ↗
DividendIFGLEXPOR
2024
18May

₹7 / share

BSE Filing ↗
Board MeetingIFGLEXPOR
2024
18May

Board Meeting

Consider and approve audited financial results, both on stan…

BSE Filing ↗
Board MeetingIFGLEXPOR
2024
3Feb

Board Meeting

consider and approve unaudited financial results

BSE Filing ↗
Board MeetingIFGLEXPOR
2023
4Nov

Board Meeting

consider and approve unaudited financial results

BSE Filing ↗
DividendIFGLEXPOR
2023
18Aug

₹7 / share

BSE Filing ↗